The Department of Medicine

Ronald H. Lands, MD

Clinical Professor
Division of Hematology and Oncology

Clinical Focus

Hematology and Oncology in the elderly, Palliative Care, Medical Ethics, Narrative Medicine

Education

Medical School
University of Tennessee, Memphis

Graduate School
Master of Fine Arts, Queen’s University of Charlotte, Charlotte, NC

Residency
University of Tennessee Center for Health Sciences, Memphis, TN

Fellowship
University of Tennessee Center for Health Sciences

Certifications

Diplomate, American Board of Internal Medicine
Diplomate, American Board of Medical Oncology
Diplomate, American Board of Hematology
Certificate of added qualifications, Geriatric Medicine
American Board of Hospice/Palliative Medicine

Professional Affiliations

Current Publications

Lands R, Martin EB, Powell D, Stuckey A, Whittle B, Guthrie S, Raj R, Kennel SJ, Wall JS..
Longitudinal PET/CT imaging with iodine ((124)i) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL Amyloidosis. Amyloid. 2023 Nov 22:1-2. doi: 10.1080/13506129.2023.2286427. Online ahead of print.

Wall JS, Martin EB, Lands R, Ramchandren R, Stuckey A, Heidel RE, Whittle B, Powell D, Richey T, Williams AD, Foster JS, Guthrie S, Kennel SJ..
Cardiac amyloid detection by PET/CT imaging of iodine ((124)i) evuzamitide ((124)i-p5+14): A phase 1/2 study. JACC Cardiovasc Imaging. 2023 Nov;16(11):1433-1448. doi: 10.1016/j.jcmg.2023.08.009.

Martin EB, Stuckey A, Powell D, Lands R, Whittle B, Wooliver C, Macy S, Foster JS, Guthrie S, Kennel SJ, Wall JS.
Clinical confirmation of pan-amyloid reactivity of radioiodinated peptide (124)I-p5+14 (AT-01) in patients with diverse types of systemic amyloidosis demonstrated by PET/CT imaging. Pharmaceuticals (Basel). 2023 Apr 21;16(4):629. doi: 10.3390/ph16040629.

Wall JS, Martin EB, Endsley A, Stuckey AC, Williams AD, Powell D, Whittle B, Hall S, Lambeth TR, Julian RR, Stabin M, Lands RH, Kennel SJ.
First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET/CT imaging. Mol Imaging Biol. 2022 Jun;24(3):479-488. doi: 10.1007/s11307-021-01681-2. Epub 2021 Nov 16.

Wall JS, Martin EB, Endsley A, Stuckey AC, Williams AD, Powell D, Whittle B, Hall S, Lambeth TR, Julian RR, Stabin M, Lands RH, Kennel SJ.
First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET/CT imaging. Mol Imaging Biol. 2022 Jun;24(3):479-488. doi: 10.1007/s11307-021-01681-2. Epub 2021 Nov 16.

Wall JS, Martin EB, Endsley A, Stuckey AC, Williams AD, Powell D, Whittle B, Hall S, Lambeth TR, Julian RR, Stabin M, Lands RH, Kennel SJ.
First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET/CT imaging. Molecular Imaging and Biology. 2021 Nov 16. [Epub ahead of print]

Wall JS, Martin EB, Endsley A, Stuckey AC, Williams AD, Powell D, Whittle B, Hall S, Lambeth TR, Julian RR, Stabin M, Lands RH, Kennel SJ.
First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET/CT imaging. Molecular Imaging and Biology. 2021 Nov 16. [Epub ahead of print]

Wall JS, Martin EB, Endsley A, Stuckey AC, Williams AD, Powell D, Whittle B, Hall S, Lambeth TR, Julian RR, Stabin M, Lands RH, Kennel SJ.
First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET/CT imaging. Molecular Imaging and Biology. 2021 Nov 16. [Epub ahead of print]

Worth H, Helmlinger K, Raj R, Heidel E, Lands R.
Thromboembolic rates are similar between intensive care unit and nonintensive care unit hospitalized patients with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): A retrospective cohort study. Clinical and Applied Thrombosis/Hemostasis. 2021 Jan-Dec;27:10760296211053315.

Worth H, Helmlinger K, Raj R, Heidel E, Lands R.
Thromboembolic rates are similar between intensive care unit and nonintensive care unit hospitalized patients with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): A retrospective cohort study. Clinical and Applied Thrombosis/Hemostasis. 2021 Jan-Dec;27:10760296211053315.

Worth H, Helmlinger K, Raj R, Heidel E, Lands R.
Thromboembolic rates are similar between intensive care unit and nonintensive care unit hospitalized patients with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): A retrospective cohort study. Clinical and Applied Thrombosis/Hemostasis. 2021 Jan-Dec;27:10760296211053315.

Current Presentations

Wall J, Heidel RE, Martin EB, Stuckey AC, Whittle BA, Powell D, Lands R, Kennel SJ. Detection and differentiation of cardiac amyloidosis using [124]I-P5+14 PET/CT imaging and the correlation with clinical biomarkers. Presented at American College of Cardiology; 2021 May 15-17; Atlanta, GA.